Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06289400
Other study ID # KaratayUOAS
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date March 1, 2024
Est. completion date June 30, 2024

Study information

Verified date February 2024
Source KTO Karatay University
Contact Osman Karaca, PhD
Phone +90 444 1251
Email osmankaracaftr@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to examine the effect of magnetic field application used in the treatment of patellofemoral pain.


Description:

The aim of this randomized controlled study is to examine the effect of magnetic field application used in the treatment of patellofemoral pain. The main question it aims to answer is; Is magnetic field therapy applied in addition to conventional treatment effective in reducing pain in individuals with Patellofemoral pain syndrome?


Recruitment information / eligibility

Status Recruiting
Enrollment 30
Est. completion date June 30, 2024
Est. primary completion date June 30, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Having been diagnosed with patellofemoral pain syndrome by an orthopedic physician - Volunteering to participate in the study - Having pain for more than eight weeks - Patients who did not undergo surgery Exclusion Criteria: - Patients diagnosed with rheumatological disease - Patients who have previously had steroid injections in the knee area - Patients with entrapment neuropathy and deformity in the lower extremity - Patients who are pregnant - Patients suffering from scoliosis, - Patients who use non-steroidal anti-inflammatory and antidepressant regularly for any reason

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Magnetic field application
The applicator (Size: 15x15 cm) has placed 1-3 cm above the skin surface at the painful area. During the treatment, treatment has applied with ready-made protocols included in the device.
Other:
Conventional treatment
Within the scope of conventional treatment, hotpack application, transcutaneous electrical stimulation (TENS), interferential current and ultrasound treatment modalities will be applied. In addition, strengthening exercises will be applied to the muscles around the hip and knee and stretching exercises will be applied to the short muscle groups.

Locations

Country Name City State
Turkey KTO Karatay University Konya

Sponsors (1)

Lead Sponsor Collaborator
KTO Karatay University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Visual Analogue Scale (VAS) A Visual Analogue Scale (VAS) is one of the pain rating scales.Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between "no pain" and "worst pain. The evaluation will be applied at the beginning of the treatment program.
Primary 36-Item Short Form Survey (SF-36) The SF-36 is a 36-item self-report measure of health-related quality of life. It has eight subscales measuring different domains of health-related quality of life: physical functioning (PF), role-physical (RP), bodily pain (BP), general health (GH), vitality (VT), social functioning (SF), role-emotional (RE), and mental health (MH). The evaluation will be applied at the beginning of the treatment program.
Primary Manual Muscle Test Manual muscle testing is based on the physiotherapist manually applying resistance to the muscle or muscle group to be evaluated. The evaluation will be applied at the beginning of the treatment program.
Primary The Lower Extremity Functional Scale (LEFS) The Lower Extremity Functional Scale (LEFS) is a questionnaire containing 20 questions about a person's ability to perform everyday tasks. The LEFS can be used by clinicians as a measure of patients' initial function, ongoing progress and outcome, as well as to set functional goals. The evaluation will be applied at the beginning of the treatment program.
See also
  Status Clinical Trial Phase
Completed NCT03542838 - Study of Resiniferatoxin for Knee Pain in Moderate to Severe Osteoarthritis Phase 1